cbdMD Inc (YCBD)
0.47
0.00 (0.00%)
USD |
NYAM |
Sep 27, 16:00
0.4742
0.00 (0.00%)
After-Hours: 20:00
cbdMD Research and Development Expense (TTM): 0.0329M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.0329M |
| March 31, 2024 | 0.0473M |
| December 31, 2023 | 0.1014M |
| September 30, 2023 | 0.173M |
| June 30, 2023 | 0.2401M |
| March 31, 2023 | 0.3293M |
| December 31, 2022 | 0.4242M |
| September 30, 2022 | 0.6334M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.9125M |
| March 31, 2022 | 1.474M |
| December 31, 2021 | 1.404M |
| September 30, 2021 | 1.423M |
| June 30, 2021 | 1.453M |
| March 31, 2021 | 0.7997M |
| December 31, 2020 | 0.7177M |
| September 30, 2020 | 0.4217M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
0.0329M
Minimum
Jun 2024
1.474M
Maximum
Mar 2022
0.6617M
Average
0.5288M
Median
Research and Development Expense (TTM) Benchmarks
| MariMed Inc | -- |
| Flora Growth Corp | 0.142M |
| NovaBay Pharmaceuticals Inc | 0.043M |
| Palatin Technologies Inc | 25.13M |
| iBio Inc | 5.185M |